Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ventricular function in patients with myocardial infarction with ST segment elevation and normal troponin I levels prior percutaneous coronary intervention. [electronic resource] by
- Kashlov, Javor K
- Donev, Ivan S
- Doneva, Jordanka G
- Valkov, Veselin D
- Kirkorova, Arpine D
- Ghenev, Peter I
- Conev, Nikolay V
- Radeva, Temenuzhka R
- Ivanov, Borislav D
- Georgieva, Zhaneta T
Producer: 20170206
In:
Bioscience trends vol. 10
Availability: No items available.
|
|
8.
|
Role of the pretreatment [electronic resource] by
- Dimitrova, Eleonora G
- Chaushev, Borislav G
- Conev, Nikolay V
- Kashlov, Javor K
- Zlatarov, Aleksandar K
- Petrov, Dilyan P
- Popov, Hristo B
- Stefanova, Nadezhda T
- Klisarova, Anelia D
- Bratoeva, Kameliya Z
- Donev, Ivan S
Producer: 20180305
In:
Bioscience trends vol. 11
Availability: No items available.
|
|
9.
|
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer. [electronic resource] by
- Petrova, Mila P
- Eneva, Mariyana I
- Arabadjiev, Jeliazko I
- Conev, Nikolay V
- Dimitrova, Eleonora G
- Koynov, Krassimir D
- Karanikolova, Teodora S
- Valev, Spartak S
- Gencheva, Radostina B
- Zhbantov, Georgi A
- Ivanova, Anika I
- Sarbianova, Iva I
- Timcheva, Constanta V
- Donev, Ivan S
Producer: 20200318
In:
Bioscience trends vol. 14
Availability: No items available.
|
|
10.
|
RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer. [electronic resource] by
- Conev, Nikolay V
- Dimitrova, Eleonora G
- Bogdanova, Margarita K
- Kashlov, Yavor K
- Chaushev, Borislav G
- Radanova, Maria A
- Petrov, Dilyan P
- Georgiev, Kaloyan D
- Bachvarov, Chavdar H
- Todorov, George N
- Kalchev, Kalin P
- Popov, Hristo B
- Manev, Rostislav R
- Donev, Ivan S
Producer: 20200406
In:
Clinical and investigative medicine. Medecine clinique et experimentale vol. 42
Availability: No items available.
|
|
11.
|
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. [electronic resource] by
- Paz-Ares, Luis
- Dvorkin, Mikhail
- Chen, Yuanbin
- Reinmuth, Niels
- Hotta, Katsuyuki
- Trukhin, Dmytro
- Statsenko, Galina
- Hochmair, Maximilian J
- Özgüroğlu, Mustafa
- Ji, Jun Ho
- Voitko, Oleksandr
- Poltoratskiy, Artem
- Ponce, Santiago
- Verderame, Francesco
- Havel, Libor
- Bondarenko, Igor
- Kazarnowicz, Andrzej
- Losonczy, György
- Conev, Nikolay V
- Armstrong, Jon
- Byrne, Natalie
- Shire, Norah
- Jiang, Haiyi
- Goldman, Jonathan W
Producer: 20191206
In:
Lancet (London, England) vol. 394
Availability: No items available.
|